Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Telmisartan
Drug ID BADD_D02147
Description Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arterial blood pressure. Recent studies suggest that telmisartan may also have PPAR-gamma agonistic properties that could potentially confer beneficial metabolic effects.
Indications and Usage Used alone or in combination with other classes of antihypertensives for the treatment of hypertension. Also used in the treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes mellitus, as well as the treatment of congestive heart failure (only in patients who cannot tolerate ACE inhibitors).
Marketing Status Prescription
ATC Code C09CA07
DrugBank ID DB00966
KEGG ID D00627
MeSH ID D000077333
PubChem ID 65999
TTD Drug ID D0N6RF
NDC Product Code 68554-0049; 43547-283; 67877-484; 65862-868; 71335-0875; 65162-292; 72241-015; 65404-007; 62512-0040; 53104-7624; 65862-867; 46708-610; 71335-1723; 62332-088; 42571-226; 0378-2921; 62332-089; 62332-087; 65162-291; 65372-1146; 71209-049; 52562-009; 68462-199; 65162-293; 53746-291; 43547-284; 55545-0701; 72241-016; 0781-5374; 45865-836; 0597-0041; 70518-2572; 31722-803; 71335-1841; 13668-156; 42571-228; 57451-1206; 0781-5378; 53746-292; 12666-0010; 68071-2591; 50090-5489; 71052-679; 63629-5682; 43547-285; 62331-032; 67877-483; 71335-1428; 55111-095; 0378-2922; 71209-051; 72761-021; 72606-507; 50090-5490; 31722-804; 50370-0015; 67877-482; 68382-471; 52286-0024; 50090-5492; 68071-4937; 68382-473; 65862-869; 68462-200; 64552-4026; 31722-802; 65862-727; 68462-201; 0597-0039; 0378-2920; 65841-806; 68071-5178; 72606-506; 46708-864; 42291-792; 42291-791; 72969-100; 53746-293; 65841-805; 70518-3300; 13668-158; 65015-845; 13668-157; 63187-951; 68382-472; 46708-609; 64220-124; 72241-017; 71209-050; 42291-790; 0781-5372; 42571-227; 65841-804; 46708-608; 63629-7230; 17511-126; 72606-508; 0597-0040; 66039-895
Synonyms Telmisartan | 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid | Pritor | BIBR 277 | BIBR-277 | Micardis
Chemical Information
Molecular Formula C33H30N4O2
CAS Registry Number 144701-48-4
SMILES CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Gastrooesophageal reflux disease07.02.02.003--
Gastroenteritis11.01.07.004; 07.19.03.001--Not Available
Gastrointestinal disorder07.11.01.0010.002560%Not Available
Gastrointestinal pain07.01.05.005--
Genital candidiasis21.10.03.001; 11.03.03.002--Not Available
Gingival bleeding24.07.02.010; 07.09.07.0010.001280%Not Available
Glaucoma06.03.01.0020.001280%
Gout14.09.01.001; 15.01.06.001--Not Available
Gravitational oedema08.01.07.005; 02.05.04.014--Not Available
Haematemesis24.07.02.011; 07.12.02.0020.001280%Not Available
Haematochezia24.07.02.012; 07.12.02.0030.002560%Not Available
Haematoma24.07.01.0010.001280%
Haematuria24.07.01.047; 20.02.01.006--
Haemoglobin decreased13.01.05.003--Not Available
Haemolytic anaemia01.06.03.0020.001280%Not Available
Haemorrhoids24.10.02.002; 07.15.03.0010.001280%
Headache17.14.01.0010.012158%
Heart rate decreased13.14.04.0010.001280%Not Available
Heart rate increased13.14.04.0020.002560%Not Available
Hepatic function abnormal09.01.02.0010.005119%Not Available
Hepatitis09.01.07.0040.001920%Not Available
Hepatocellular injury09.01.07.008--Not Available
Hiatus hernia22.09.02.004; 07.16.01.0010.001280%Not Available
Hyperammonaemia14.10.01.001; 09.01.02.0020.001280%Not Available
Hypercholesterolaemia14.08.01.001--Not Available
Hyperhidrosis23.02.03.004; 08.01.03.0280.003199%
Hyperkalaemia14.05.03.0010.007679%
Hypernatraemia14.05.04.0010.002560%
Hypersensitivity10.01.03.003--
Hypertension24.08.02.0010.009598%
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 13 Pages